Zepbound®

Zepbound® is an FDA-approved branded Tirzepatide injection used for chronic weight management in eligible patients. Tirzepatide is a dual GIP and GLP-1 receptor agonist involved in appetite regulation, satiety signaling, glucose-dependent insulin activity, and metabolic function. Through MEDVera, Zepbound® may be prescribed when a licensed clinician determines that branded tirzepatide therapy is appropriate. Eligibility is based on medical history, treatment goals, current medications, contraindication screening, and provider review.